Denis Bedoret

Denis Bedoret serves as the Chief Executive Officer of Imcyse SA since September 2020, leading a clinical-stage biopharmaceutical company focused on innovative immunotherapies for severe chronic autoimmune diseases. In addition to this role, Denis Bedoret holds various positions including Board Member at Ncardia and EXOTHERA, and Scientific Advisory Board member at Kiniciti and SRIW. Denis Bedoret previously served as President of MaSTherCell Global and has held key positions at QUALITY ASSISTANCE and McKinsey & Company. With a strong academic background in immunology, including a postdoctoral training at Harvard Medical School and a PhD from the University of Liège, Denis Bedoret has extensive experience in both research and industry.